WCN26-631 Glomerular Endothelial Cell-Derived ET-1 Promotes Podocyte Injury via ETAR/PKM2 Signaling in Sunitinib-Associated Nephrotoxicity

Read full text Summarise with VIRAT
Authors: Baokui Ye, zhiling zhang, Xuefei Tian
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Sunitinib, a small-molecular tyrosine kinase inhibitor (TKI), is widely used as a first-line treatment for multiple malignancies but is limited by nephrotoxicity, most notably proteinuria. Preventing and managing sunitinib-associated nephrotoxicity remains challenging due to incomplete understanding of its mechanisms.

Fields of Study & Subjects

Renal Diseases and Glomerulopathies Acute Kidney Injury Research Chemotherapy-induced organ toxicity mitigation

Publication details

Journal / source
Kidney International Reports
Volume
11
Issue
4
Pages
104149–104149
Publication date
25 March 2026
Language
EN